• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

沙特阿拉伯不同地区的 CEA、CA125 和 CA15-3 血清肿瘤标志物的流行情况。

Prevalence of CEA, CA 125, and CA 15-3 serum tumour markers in different regions of Saudi Arabia.

机构信息

From the Department of Medical Laboratory Sciences (Ashi, Almaghrabi, Alrayes), Faculty of Applied Medical Sciences; from the Regenerative Medicine Unit (Ashi), King Fahd Medical Research Center; from the Center of Innovations in Personalized Medicine (Almaghrabi); from the Department of Medicine (Al-Hajeili); from the Department of Pathology (Al-Maghrabi); from the Department of Surgery (Trabulsi), Faculty of Medicine, King Abdulaziz University, from King Abdullah International Medical Research Centre (Alsiary), King Saud bin Abdulaziz University for Health Sciences, and from the Research and Development Unit (Alghuraibi), Al Borg Medical Laboratories, Al Borg Diagnostics, Jeddah, Kingdom of Saudi Arabia.

出版信息

Saudi Med J. 2024 Jun;45(6):565-571. doi: 10.15537/smj.2024.45.6.20230878.

DOI:10.15537/smj.2024.45.6.20230878
PMID:38830664
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11147600/
Abstract

OBJECTIVES

To study the prevalence of tumor marker (TM) carcinoembryonic antigen (CEA), cancer antigen 125 (CA 125), and cancer antigen 15-3 (CA 15-3) levels in the Saudi population, based on gender, age, and demographic region, and whether the patients were referred by a hospital or self-referred.

METHODS

Retrospective analysis was carried out on 7,019 samples gathered from the Western, Northern, Central, Southern, and Eastern regions of Saudi Arabia between 2021-2022. The TMs were categorized into normal and abnormal levels, according to the reference ranges. Statistical analysis was carried out to assess the relations between variants (age groups, gender, and demographic regions) using the Chi-square test, and their correlations were assessed using Spearman's test.

RESULTS

Among all patients, CEA, CA 125, and CA 15-3 levels were found to be significantly correlated with age (=0.0001). The CEA and CA 15-3 levels increased in both males and females with age. The CA 125 was shown to have an abnormally increased level in males with age.

CONCLUSION

Increased levels of CEA, CA 125, and CA 15-3 TMs in the study population were significantly correlated with age. The CEA and CA 15-3 levels were within the normal range, while CA 125 levels were above the normal range in the older male population. These results suggest that the utilization of such TMs is age dependent and would have validity if applied with other parameters.

摘要

目的

基于性别、年龄和地域因素,研究沙特人群中肿瘤标志物(TM)癌胚抗原(CEA)、癌抗原 125(CA 125)和癌抗原 15-3(CA 15-3)的水平,并分析患者是由医院转诊还是自行就诊。

方法

对 2021 年至 2022 年间采集自沙特阿拉伯西部、北部、中部、南部和东部地区的 7019 例样本进行回顾性分析。根据参考范围,将 TM 分为正常和异常水平。采用卡方检验评估年龄组、性别和地域等变异因素之间的关系,采用斯皮尔曼检验评估其相关性。

结果

在所有患者中,CEA、CA 125 和 CA 15-3 水平与年龄呈显著相关(=0.0001)。CEA 和 CA 15-3 水平随年龄增长而在男女两性中均升高,CA 125 则表现为男性随年龄增长而异常升高。

结论

研究人群中 CEA、CA 125 和 CA 15-3 的水平升高与年龄显著相关。CEA 和 CA 15-3 水平在正常范围内,而老年男性的 CA 125 水平高于正常范围。这些结果表明,此类 TM 的使用与年龄相关,如果与其他参数结合使用将具有有效性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8be1/11147600/16bc8fdf859e/SaudiMedJ-45-6-565_1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8be1/11147600/16bc8fdf859e/SaudiMedJ-45-6-565_1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8be1/11147600/16bc8fdf859e/SaudiMedJ-45-6-565_1.jpg

相似文献

1
Prevalence of CEA, CA 125, and CA 15-3 serum tumour markers in different regions of Saudi Arabia.沙特阿拉伯不同地区的 CEA、CA125 和 CA15-3 血清肿瘤标志物的流行情况。
Saudi Med J. 2024 Jun;45(6):565-571. doi: 10.15537/smj.2024.45.6.20230878.
2
Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers.基于LOCI™技术的肿瘤标志物检测法对妇科癌症中肿瘤标志物CA 15-3、CA 125、癌胚抗原(CEA)、CA 19-9和甲胎蛋白(AFP)的临床检测性能
Tumour Biol. 2017 Oct;39(10):1010428317730246. doi: 10.1177/1010428317730246.
3
Clinical utility of tumour marker velocity of cancer antigen 15-3 (CA 15-3) and carcinoembryonic antigen (CEA) in breast cancer surveillance.肿瘤标志物癌抗原 15-3(CA 15-3)和癌胚抗原(CEA)速度在乳腺癌监测中的临床应用。
Breast. 2020 Aug;52:95-101. doi: 10.1016/j.breast.2020.05.005. Epub 2020 May 20.
4
Serum cytokeratin fragment 21.1 (CYFRA 21.1) as tumour marker for breast cancer: comparison with carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA).血清细胞角蛋白片段21.1(CYFRA 21.1)作为乳腺癌肿瘤标志物:与糖类抗原15.3(CA 15.3)和癌胚抗原(CEA)的比较
Clin Chem Lab Med. 2002 Mar;40(3):298-303. doi: 10.1515/CCLM.2002.047.
5
Prevalence of abnormal levels of serum tumour markers in elderly people.老年人血清肿瘤标志物水平异常的患病率。
Age Ageing. 1996 Jan;25(1):45-50. doi: 10.1093/ageing/25.1.45.
6
Long-term prognostic study of carcinoembryonic antigen (CEA) and carbohydrate antigen 15-3 (CA 15-3) in breast cancer.癌胚抗原(CEA)和糖类抗原15-3(CA 15-3)在乳腺癌中的长期预后研究
Int J Clin Oncol. 2008 Oct;13(5):447-51. doi: 10.1007/s10147-008-0773-3. Epub 2008 Oct 23.
7
Serum concentrations of CA 125, CA 15-3, CA 19-9 and CEA in normal pregnancy: a longitudinal study.正常妊娠时血清 CA125、CA15-3、CA19-9 和 CEA 浓度:一项纵向研究。
Arch Gynecol Obstet. 2012 Mar;285(3):579-84. doi: 10.1007/s00404-011-2025-4. Epub 2011 Jul 27.
8
Tumor markers in the early detection of tumor recurrence in breast cancer patients: CA 125, CYFRA 21-1, HER2 shed antigen, LDH and CRP in combination with CEA and CA 15-3.肿瘤标志物在乳腺癌患者肿瘤复发早期检测中的应用:CA 125、细胞角蛋白19片段(CYFRA 21-1)、人表皮生长因子受体2(HER2)脱落抗原、乳酸脱氢酶(LDH)和C反应蛋白(CRP)联合癌胚抗原(CEA)和糖类抗原15-3 。
Clin Chim Acta. 2016 Oct 1;461:1-7. doi: 10.1016/j.cca.2016.07.014. Epub 2016 Jul 22.
9
The diagnostic value of serum tumor markers CEA, CA19-9, CA125, CA15-3, and TPS in metastatic breast cancer.血清肿瘤标志物癌胚抗原(CEA)、糖类抗原19-9(CA19-9)、糖类抗原125(CA125)、糖类抗原15-3(CA15-3)及组织多肽特异性抗原(TPS)在转移性乳腺癌中的诊断价值
Clin Chim Acta. 2017 Jul;470:51-55. doi: 10.1016/j.cca.2017.04.023. Epub 2017 Apr 27.
10
Influence of cardiopulmonary resuscitation on levels of tumour markers.心肺复苏对肿瘤标志物水平的影响。
Eur J Cancer Care (Engl). 2006 Jul;15(3):252-6. doi: 10.1111/j.1365-2354.2005.00648.x.

引用本文的文献

1
Unveiling the Diagnostic Significance of Calprotectin in Serous Ovarian Carcinoma.揭示钙卫蛋白在浆液性卵巢癌中的诊断意义。
Life (Basel). 2025 Jul 8;15(7):1080. doi: 10.3390/life15071080.

本文引用的文献

1
Establishment and validation of reference intervals for tumor markers (AFP, CEA, CA19-9, CA15-3, CA125, PSA, HE4, Cyfra 21-1, and ProGRP) in primary care centers in Korea: A cross-sectional retrospective study.韩国基层医疗中心肿瘤标志物(甲胎蛋白、癌胚抗原、糖类抗原19-9、糖类抗原15-3、糖类抗原125、前列腺特异抗原、人附睾蛋白4、细胞角蛋白19片段、胃泌素释放肽前体)参考区间的建立与验证:一项横断面回顾性研究
Health Sci Rep. 2023 Feb 11;6(2):e1107. doi: 10.1002/hsr2.1107. eCollection 2023 Feb.
2
Clinical usefulness of circulating tumor markers.循环肿瘤标志物的临床应用价值
Clin Chem Lab Med. 2022 Nov 17;61(5):895-905. doi: 10.1515/cclm-2022-1090. Print 2023 Apr 25.
3
Prospective evaluation of 92 serum protein biomarkers for early detection of ovarian cancer.
前瞻性评估 92 种血清蛋白生物标志物用于早期卵巢癌检测。
Br J Cancer. 2022 May;126(9):1301-1309. doi: 10.1038/s41416-021-01697-z. Epub 2022 Jan 14.
4
The ever-increasing importance of cancer as a leading cause of premature death worldwide.癌症作为全球范围内导致过早死亡的主要原因,其重要性日益增加。
Cancer. 2021 Aug 15;127(16):3029-3030. doi: 10.1002/cncr.33587. Epub 2021 Jun 4.
5
Limited usefulness of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for gastrointestinal and whole-body cancer screening.血清癌胚抗原和糖类抗原 19-9 水平对胃肠道和全身癌症筛查的作用有限。
Sci Rep. 2020 Oct 23;10(1):18202. doi: 10.1038/s41598-020-75319-8.
6
Serum CA19-9, CA-125 and CEA as tumor markers for mucinous ovarian tumors.血清CA19-9、CA-125和癌胚抗原作为黏液性卵巢肿瘤的肿瘤标志物。
J Obstet Gynaecol Res. 2020 Nov;46(11):2287-2291. doi: 10.1111/jog.14427. Epub 2020 Aug 23.
7
The prognostic significance of preoperative tumor marker (CEA, CA15-3) elevation in breast cancer patients: data from the Korean Breast Cancer Society Registry.术前肿瘤标志物(CEA、CA15-3)升高对乳腺癌患者预后的意义:来自韩国乳腺癌学会注册中心的数据。
Breast Cancer Res Treat. 2019 Oct;177(3):669-678. doi: 10.1007/s10549-019-05357-y. Epub 2019 Jul 16.
8
Identifying the Best Marker Combination in CEA, CA125, CY211, NSE, and SCC for Lung Cancer Screening by Combining ROC Curve and Logistic Regression Analyses: Is It Feasible?通过 ROC 曲线和逻辑回归分析联合确定 CEA、CA125、CY211、NSE 和 SCC 在肺癌筛查中的最佳标志物组合:是否可行?
Dis Markers. 2018 Oct 1;2018:2082840. doi: 10.1155/2018/2082840. eCollection 2018.
9
Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer.评估血清 CEA、CA19-9、CA72-4、CA125 和铁蛋白作为结直肠癌的诊断标志物和临床参数的影响因素。
Sci Rep. 2018 Feb 9;8(1):2732. doi: 10.1038/s41598-018-21048-y.
10
Evaluation of a Serum Lung Cancer Biomarker Panel.血清肺癌生物标志物组合的评估
Biomark Insights. 2018 Jan 15;13:1177271917751608. doi: 10.1177/1177271917751608. eCollection 2018.